Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
4(31%)
Results Posted
60%(3 trials)

Phase Distribution

Ph phase_2
5
38%
Ph phase_1
1
8%
Ph phase_4
4
31%
Ph phase_3
2
15%

Phase Distribution

1

Early Stage

5

Mid Stage

6

Late Stage

Phase Distribution12 total trials
Phase 1Safety & dosage
1(8.3%)
Phase 2Efficacy & side effects
5(41.7%)
Phase 3Large-scale testing
2(16.7%)
Phase 4Post-market surveillance
4(33.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

5 of 5 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

4

trials recruiting

Total Trials

13

all time

Status Distribution
Active(8)
Completed(5)

Detailed Status

Completed5
Recruiting4
Not yet recruiting3
Enrolling by invitation1

Development Timeline

Analytics

Development Status

Total Trials
13
Active
4
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (8.3%)
Phase 25 (41.7%)
Phase 32 (16.7%)
Phase 44 (33.3%)

Trials by Status

enrolling_by_invitation18%
not_yet_recruiting323%
recruiting431%
completed538%

Recent Activity

Clinical Trials (13)

Showing 13 of 13 trials
NCT07555743Phase 4

Efficacy and Safety of Daridorexant in Patients With Major Depressive Disorder and Insomnia

Not Yet Recruiting
NCT05924425Phase 4

Daridorexant to Treat Insomnia in Patients With Mild Cognitive Impairment and Mild to Moderate Alzheimer Disease

Recruiting
NCT07532252Phase 2

Daridorexant for Alcohol Use Disorder

Not Yet Recruiting
NCT07267559Phase 4

Dual Orexin Antagonism and Emotion and Affective Processing Study

Recruiting
NCT05423717Phase 2

Dose-finding Study Assessing the Efficacy, Safety, and Pharmacokinetics of Daridorexant in Subjects Aged 10 to < 18 Years With Insomnia Disorder

Completed
NCT07328594Phase 4

Impact of Daridorexant on Sleep, Daytime Alertness, and Smoking

Not Yet Recruiting
NCT07217912Phase 2

Daridorexant to Prevent Post-cardiotomy Delirium

Recruiting
NCT07213349Phase 2

Daridorexant for Alzheimer Disease Prevention

Recruiting
NCT06630390Phase 2

Daridorexant to Prevent Delirium After Heart Surgery

Completed
NCT06311864

Real-World Observational Study on Patient-Reported Outcomes in the Treatment of Insomnia with Daridorexant in Canada

Enrolling By Invitation
NCT05702177Phase 1

A Study of the Effect of Daridorexant on Nighttime Body Posture, the Noise Level Required to Wake up, and the Ability to Remember Words Previously Presented

Completed
NCT03545191Phase 3

Study to Assess the Efficacy and Safety of ACT-541468 (Daridorexant) in Adult and Elderly Subjects With Insomnia Disorder

Completed
NCT03679884Phase 3

Study to Assess the Long Term Safety and Tolerability of ACT-541468 (Daridorexant) in Adult and Elderly Subjects Suffering From Difficulties to Sleep

Completed

All 13 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
13